News

Bayer HealthCare and Genzyme have received regulatory approvals for the strategic alliance announced on March 31, 2009. With the approval, the legal closing of the transaction is now

Results of phase Ib clinical trial for L-CsA, inhaled liposomal cyclosporine A, were published in Journal of Aerosol Medicine and Pulmonary Drug Delivery. L-CsA is delivered via an

Stiefel has declared the completion and analysis of phase III clinical trial for Hyphanox (itraconazole) tablets, for the treatment of onychomycosis. The study compared once daily oral dosing

The study will directly compare the two basal insulins in an exclusively once daily regimen. Outcomes measured in the study will include efficacy, effect on weight and hypoglycaemia

PolyMedix has received a research contract worth $1.6 million from the Defense Threat Reduction Agency (DTRA), to develop new defensin-mimetic antibiotic compounds. The primary goal of the contract

The company estimates that Diclofenac Sodium eye drops will generate revenues of $0.5 million during the first year of sales. Diclofenac Sodium eye drops are meant for the

Delcath is enrolling patients in a phase II clinical trial testing its proprietary drug delivery system, known as the Delcath Percutaneous Hepatic Perfusion (PHP) System, with ultra high

Cordex Pharma has announced that FDA has approved the design of Phase 2b/3 clinical trials evaluating its lead product ATPace as an antiarrhytmic drug for the treatment of

Schering Plough has announced that the European Medicines Agency (EMEA) has validated the marketing authorization application (MAA) for Sycrest (asenapine) sublingual tablets for the treatment of schizophrenia and